Literature DB >> 30770975

A Helicobacter pylori screening and treatment program to eliminate gastric cancer among junior high school students in Saga Prefecture: a preliminary report.

Toshihiko Kakiuchi1, Muneaki Matsuo2, Hiroyoshi Endo3, Aiko Nakayama2, Keiko Sato4, Ayako Takamori4, Kazumi Sasaki5, Mitsuhiro Takasaki6, Megumi Hara7, Yasuhisa Sakata8, Masumi Okuda9, Shogo Kikuchi10, Yuichiro Eguchi8, Hirokazu Takahashi8, Keizo Anzai8, Kazuma Fujimoto8.   

Abstract

BACKGROUND: To present the strategies and preliminary findings of the first 3 years after implementing a Helicobacter pylori screening and eradication program to prevent gastric cancer in Saga Prefecture.
METHODS: A screening and treatment program to eradicate H. pylori from third-grade junior high students was started in Saga Prefecture in 2016, using local governmental grants. Screening was with urinary anti-H. pylori antibody tests, followed by H. pylori stool antigen tests for students who were antibody positive. Those positive on both tests underwent H. pylori eradication by triple therapy based on a potassium-competitive acid blocker.
RESULTS: From 2016 to 2018, the participation rate was 83.1% and the H. pylori infection rate was 3.1% (660/21,042). The participation rates were higher in 2017 (85.4%) and 2018 (85.9%) compared with 2016 (78.5%) (P < 0.0001), and the infection rate also decreased in a time-dependent manner (2016: 3.6%, 2017: 3.3%, 2018: 2.5%, P = 0.0001). In total, 501 students positive for H. pylori received eradication therapy (85.1% success) and adverse events occurred in 20 of these (4.0%). However, no serious complications occurred.
CONCLUSIONS: The H. pylori screening and eradication project for school students in Saga Prefecture has started successfully and we have seen both a steady increase in the participation rate and a steady decrease in the infection rate, without major safety concerns.

Entities:  

Keywords:  Adverse effect; Eradication; Potassium-competitive acid blocker; Prevention

Year:  2019        PMID: 30770975     DOI: 10.1007/s00535-019-01559-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  51 in total

1.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

2.  Reliability of urinary tests for antibody to Helicobacter pylori in patients with pulmonary tuberculosis.

Authors:  Takatsugu Yamamoto; Taro Ishii; Tomotaka Kawakami; Yoko Sase; Chiaki Horikawa; Nozomu Aoki; Masaki Sanaka; Yasushi Kuyama
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

3.  Results of triple eradication therapy in Japanese children: a retrospective multicenter study.

Authors:  Seiichi Kato; Mutsuko Konno; Shun-Ichi Maisawa; Hitoshi Tajiri; Norikazu Yoshimura; Toshiaki Shimizu; Shigeru Toyoda; Yoshiko Nakayama; Kazuie Iinuma
Journal:  J Gastroenterol       Date:  2004-09       Impact factor: 7.527

4.  Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection.

Authors:  A M Ekström; M Held; L E Hansson; L Engstrand; O Nyrén
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

5.  Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.

Authors:  Takahisa Furuta; Emad M El-Omar; Fang Xiao; Naohito Shirai; Misako Takashima; Haruhiko Sugimura; Haruhiko Sugimurra
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

6.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Authors:  Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

7.  Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population.

Authors:  M Asaka; T Kimura; M Kudo; H Takeda; S Mitani; T Miyazaki; K Miki; D Y Graham
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

Review 8.  The use of proton pump inhibitors in children: a comprehensive review.

Authors:  Troy E Gibbons; Benjamin D Gold
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils.

Authors:  Koji Nozaki; Nobuyuki Shimizu; Yuzuru Ikehara; Manami Inoue; Tetsuya Tsukamoto; Ken-ichi Inada; Harunari Tanaka; Toshiko Kumagai; Michio Kaminishi; Masae Tatematsu
Journal:  Cancer Sci       Date:  2003-03       Impact factor: 6.716

10.  Effect of age on the relationship between gastric cancer and Helicobacter pylori. Tokyo Research Group of Prevention for Gastric Cancer.

Authors:  S Kikuchi; T Nakajima; O Kobayashi; T Yamazaki; M Kikuichi; K Mori; S Oura; H Watanabe; H Nagawa; R Otani; N Okamoto; M Kurosawa; H Anzai; T Kubo; T Konishi; S Futagawa; N Mizobuchi; O Kobori; R Kaise; T Sato; Y Inaba; O Wada
Journal:  Jpn J Cancer Res       Date:  2000-08
View more
  8 in total

1.  Clinical Evaluation of a Novel Stool Antigen Test Using Bioluminescent Enzyme Immunoassay for Detecting Helicobacter pylori.

Authors:  Toshihiko Kakiuchi; Muneaki Matsuo; Yasuhisa Sakata; Kazuma Fujimoto
Journal:  Can J Gastroenterol Hepatol       Date:  2022-04-21

Review 2.  Diagnosis and treatment of Helicobacter pylori infections in children and elderly populations.

Authors:  Chao Peng; Yi Hu; Zhong-Ming Ge; Quan-Ming Zou; Nong-Hua Lyu
Journal:  Chronic Dis Transl Med       Date:  2020-01-08

3.  Atrophic gastritis and chronic diarrhea due to Helicobacter pylori infection in early infancy: A case report.

Authors:  Toshihiko Kakiuchi; Aiko Nakayama; Ryo Shimoda; Muneaki Matsuo
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

4.  Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test reagent.

Authors:  Toshihiko Kakiuchi; Kazutoshi Hashiguchi; Ichiro Imamura; Aiko Nakayama; Ayako Takamori; Masumi Okuda; Muneaki Matsuo
Journal:  BMC Gastroenterol       Date:  2020-11-23       Impact factor: 3.067

5.  Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study.

Authors:  Toshihiko Kakiuchi; Kentaroh Yamamoto; Ichiro Imamura; Kazutoshi Hashiguchi; Hiroharu Kawakubo; Daisuke Yamaguchi; Yasuhiko Fujioka; Masumi Okuda
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

6.  Lifetime incidence risk for gastric cancer in the Helicobacter pylori-infected and uninfected population in Japan: A Monte Carlo simulation study.

Authors:  Sayo Kawai; Chaochen Wang; Yingsong Lin; Tae Sasakabe; Masumi Okuda; Shogo Kikuchi
Journal:  Int J Cancer       Date:  2021-09-04       Impact factor: 7.316

7.  Helicobacter pylori infection-induced changes in the intestinal microbiota of 14-year-old or 15-year-old Japanese adolescents: a cross-sectional study.

Authors:  Toshihiko Kakiuchi; Yoshiki Tanaka; Hiroshi Ohno; Muneaki Matsuo; Kazuma Fujimoto
Journal:  BMJ Open       Date:  2021-07-02       Impact factor: 2.692

8.  High Prevalence of Helicobacter pylori Infection in Special Needs Schools in Japan.

Authors:  Toshihiko Kakiuchi; Ayako Takamori; Muneaki Matsuo
Journal:  Front Pediatr       Date:  2021-07-08       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.